Dan Mandell

Company: GRO Biosciences

Job title: Chief Executive Officer & Co- Founder

Seminars:

Inducing Immune Tolerance with Glycan-Containing NSAAs: In Vivo & In Vitro Assays to Validate Efficacy 2:15 pm

Understanding current approaches to treating autoimmune disease and attenuating immunogenicity of therapeutics broadly suppress the immune system Tolerizing patients to specific antigens is a holy-grail challenge that can displace systemic immunosuppression Illuminating the in vivo and in vitro assays used to validate efficacy for the immune tolerance approach Highlighting GROBio’s ProGly approach to immunotolerization enables…Read more

day: Conference Day Two